Cannabis prohibitionist group Smart Approaches to Marijuana (SAM) responded to claims on Nov. 25 that it improperly communicated with the Drug Enforcement Administration (DEA) leading up to next week’s cannabis rescheduling hearing.The hearing, to determine the proper schedule for cannabis under the Controlled Substances Act (CSA), will commence with preliminary proceedings on … [Read more...] about Smart Approaches to Marijuana Responds to Claims It Colluded With DEA
DEA
DEA Denies Collusion Allegations Ahead of Cannabis Rescheduling Hearing
The Drug Enforcement Administration (DEA) responded to a slew of allegations on Nov. 25, including that it engaged in illegal communications and conspired with a prohibitionist group ahead of a cannabis rescheduling hearing that is set to begin next week. A pair of cannabis rescheduling advocates whom the DEA selected to be among the 25 designated participants for the … [Read more...] about DEA Denies Collusion Allegations Ahead of Cannabis Rescheduling Hearing
DEA Reschedules Rescheduling, and I’m Feeling a Little Like Charlie Brown Trying to Kick the Football
No, it’s not (just) a cruel play on words. Last week, the Drug Enforcement Administration announced that a much-anticipated public hearing on the proposal to reschedule marijuana was being pushed from early December until the first quarter of 2025. I’m not sure I specifically predicted this, but it’s just about the most predictable thing ever. And it has a number of people … [Read more...] about DEA Reschedules Rescheduling, and I’m Feeling a Little Like Charlie Brown Trying to Kick the Football
DEA Calls For Increased Production Of Some Psychedelics For Research, As Marijuana Quotas Level Out Ahead Of Scheduling Decision
The Drug Enforcement Administration (DEA) has released new quotas for the production of Schedule I and Schedule II controlled substances for research purposes—calling for an increase in the manufacturing of the psychedelics ibogaine, psilocybin and psilocyn, while continuing to maintain stable quotas for other substances such as marijuana, THC and MDMA. As DEA prepares to hold … [Read more...] about DEA Calls For Increased Production Of Some Psychedelics For Research, As Marijuana Quotas Level Out Ahead Of Scheduling Decision
Slow Your Roll: IRS Reminds Taxpayers That Cannabis Has Not Yet Been Reclassified
Weeks after the U.S. Drug Enforcement Administration (DEA) announced that it would move to reclassify cannabis as a less dangerous drug, the IRS is reminding taxpayers that marijuana remains a Schedule I controlled substance and is subject to the limitations of the tax code. In other words, the federal tax laws related to cannabis sales have not changed. Legalization Of … [Read more...] about Slow Your Roll: IRS Reminds Taxpayers That Cannabis Has Not Yet Been Reclassified
DEA Report Reflects Average Potency of THC in Illegal Cannabis at 16%
The Drug Enforcement Administration (DEA) recently released a report on May 9 with details about its 2024 National Drug Threat Assessment (NDTA), which is dedicated to compiling data in relation to illegal drugs and trafficking trends within the U.S. DEA Administrator Anne Milgram introduced the report to warn of the many threats to public safety as well as national security. … [Read more...] about DEA Report Reflects Average Potency of THC in Illegal Cannabis at 16%
DEA Publishes Proposed Rules To Reschedule Marijuana
The path toward the federal rescheduling of marijuana takes a step forward with the DEA's publication of proposed rules open to comments. The Drug Enforcement Administration published yesterday proposed rules in the U.S. Federal Register to reschedule marijuana from Schedule I to Schedule III of the Controlled Substances Act. This represents a further concrete step forward in … [Read more...] about DEA Publishes Proposed Rules To Reschedule Marijuana
Fentanyl Dealer on Snapchat Who Caused Deadly Overdoses Gets 20 Years in Federal Prison
A man who used Snapchat to sell fake oxycodone pills that actually contained fentanyl—leading to the death of a teenage girl as well as several other overdoses—faces 20 years in prison. Jeremial Lee Leach, 20, of Evansville, Indiana, has been sentenced to 20 years in federal prison, followed by five years of supervised release, after pleading guilty to one count of Distribution … [Read more...] about Fentanyl Dealer on Snapchat Who Caused Deadly Overdoses Gets 20 Years in Federal Prison
DEA Moves To Reclassify Cannabis Under Schedule III in Historic Move, Report Indicates
The U.S. Drug Enforcement Administration (DEA), under the Biden administration, will move to reclassify cannabis under Schedule III, meaning its medical benefits will be recognized by the federal government, the Associated Press first reported today. By all accounts, it’s a historic move by the DEA and the federal government as the plant was wrongly classified as a substance … [Read more...] about DEA Moves To Reclassify Cannabis Under Schedule III in Historic Move, Report Indicates
Congressman Presses DEA for Answers on Ongoing Cannabis Scheduling Review
Nearly two months after U.S. Rep. Earl Blumenauer, D-Ore., received a reply from the U.S. Drug Enforcement Administration (DEA) in response to he and 30 of his colleagues urging the agency to end federal cannabis prohibition, the congressman submitted yet another letter to the DEA demanding answers on the agency’s ongoing cannabis scheduling review. In a Feb. 8 letter addressed … [Read more...] about Congressman Presses DEA for Answers on Ongoing Cannabis Scheduling Review
